Synthesis of new compounds containing the 2,3-dihydro[1,4]dioxino[2,3-b]pyridine heterocyclic system as a substructure

Tetrahedron

Volumn 59, Issue 20, 2003, Pages 3665-3672

  Soukri, M ^a,b   Lazar, S ^b   Pujol, M D ^c   Akssira, M ^b   Leger, J M ^d   Jarry, C ^d   Guillaumet, G ^a  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b HASSAN II UNIVERSITY   (Morocco)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Laboratoire de Pharmacochimie   (France)

Author keywords

2,3 dihydro spiro 1,4 dioxino 2,3 b pyridines; 5 HT1A serotonin receptors; Smiles rearrangement

Indexed keywords

2 CHLORO 3 PYRIDINOL; 2 NITRO 3 PYRIDINOL; 2,3 DIHYDROSPIRO(1,4 DIOXINO[2,3 B]PYRIDINE) 2,3' PYRROLIDINE; 2,3 DIHYDROSPIRO(1,4 DIOXINO[2,3 B]PYRIDINE) 2,4' PIPERIDINE; 2,3 DIHYDROSPIRO(1,4 DIOXINO[2,3 B]PYRIDINE) 3,3' PYRROLIDINE; 2,3 DIHYDROSPIRO(1,4 DIOXINO[2,3 B]PYRIDINE) 3,4' PIPERIDINE; 2,3 DIHYDROSPIRO[1,4]DIOXINO[2,3 B]PYRIDINE 3,3' PYRROLIDINE; 2,3 DIHYDROSPIRO[1,4]DIOXINO[2,3 B]PYRIDINE 3,4' PIPERIDINE; 2,3 DIHYDRO[1,4]DIOXINO[2,3 B]PYRIDINE; 8 [4 (1,4 BENZODIOXAN 2 YLMETHYLAMINO)BUTYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALCOHOL DERIVATIVE; HETEROCYCLIC COMPOUND; OSEMOZOTAN; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COLUMN CHROMATOGRAPHY; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; ISOMER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; X RAY DIFFRACTION;

EID: 0038403548     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(03)00513-1     Document Type: Article

References (30)

1. Martin G.R. IUPHAR Compendium of Receptors, Characterization and Classification. 1988;IUPHAR Media. p 167.
2. Raymond J.R., Mukhin Y.V., Gettys T.W., Garnovskaya M.N., Br. J. Pharmacol. 127:1999;175.
3. Romero A.G., McColl R.B. Ann. Rep. Med. Chem. 270:1992;21.
4. Hibert M.F., Gittos M.W., Milddlemiss D.N., Mir A.K., Fozard J.R. J. Med. Chem. 31:1988;1087.
5. Nikam S.S., Martin A.R., Nelson D.L. J. Med. Chem. 31:1988;1965.
6. Kuipers W., Kouse C.G., Van Wijngaarden I., Standaar P.J., Tulp M., Th M., Veldman N., Spek A.L., Ijzerman A.P. J. Med. Chem. 40:1997;300.
7. Uchida M., Kentaro I., Tameda C., Miyauchi T. Prog. Neuro-Psycopharmacol. Biol. Psychiat. 19:1995;1201.
8. Matsuda T., Yoshikawa T., Suzuki M., Asano S., Somboonthum P., Takuma K., Nakano Y., Morita T., Nakasu Y., Kim H.S., Egawa M., Tobe A., Baba A. Jpn. J. Pharmacol. 69:1995;366.
9. Comoy C., Benarab A., Monteil A., Leinot M., Massingham R., Guillaumet G. Med. Chem. Res. 6:1996;392.
10. Comoy C., Benarab A., Leinot M., Monteil A., Guillaumet G. Il Farmaco. 54:1999;791.
11. (a) Benarab A., Poirot P., Guillaumet G. Heterocycles. 36:1993;1589
12. (b) Benarab A., Guillaumet G. Heterocycles. 36:1993;2327
13. (c) Joseph B., Benarab A., Guillaumet G. Heterocycles. 38:1994;1355
14. (d) Benarab A., Comoy C., Guillaumet G. Heterocycles. 38:1994;1641
15. (e) Soukri M., Lazar S., Akssira M., Guillaumet G. Org. Lett. 2:2000;1557.
16. (a) Klioze S.S., Allen R.C., Wilker J.C., Woodward D.L. J. Med. Chem. 23:1980;677
17. (b) Klein J.T., Davis L., Effland R.C.J. Heterocycl. Chem. 24:1987;725.
18. (a) Efange S.M.N., Kamath A.P., Khare A.B., Kung M.P., Mach R.H., Parsons S.M. J. Med. Chem. 40:1997;3905
19. (b) Freund R., Mederski W.K.R. Helv. Chim. Acta. 83:2000;1247.
20. Epoxides 2 and 3 were prepared, respectively, from N-benzyl-3-pyrrolidinone and N-benzyl-4-piperidone according to the method described by Popp F.D., Watts R.F. J. Heterocycl. Chem. 15:1978;675.
21. Soukri, M.; Lazar, S.; Leger, J. M.; Jarry, C.; Akssira, M.; Guillaumet, G. IXèmes Conférences Européennes du Groupement des Pharmacochimistes de l'ARC Atlantique, Tours, 11-12 septembre 2000.
22. (a) Truce W.E., Kreider E.M., Brand W.W. Org. React. 18:1970;99
23. (b) Proudfoot J.R., Patel U.R., Kapadia S.R., Hargrave K.D. J. Med. Chem. 38:1995;1406.
24. Hammarberg E., Nordvall G., Leideborg R., Nylof N., Hanson S., Johansson L., Thorberg S.O., Tolf B.R., Svantesson G.T., Mohell N., Ahlgren C., Westlind-Danielsson A., Csoregh I., Johansson R. J. Med. Chem. 43:2000;2850.
25. Lopez-Rodriguez M.L., Morcillo M.J., Fernandez E., Rosado M.L., Pardo L., Schaper K. J. Med. Chem. 44:2001;198.
26. Lopez-Rodriguez M.L., Vicente B., Deuoi X., Barrondo S., Olivella M., Morcillo M.J., Behamu B., Ballesteros J.A. Mol. Pharmacol. 62:2002;15.
27. Tuladhar S.M., D'Silva C. Tetrahedron Lett. 33:1992;2203.
28. Podona T., Guardiola-Lemaitre B., Caignard D.H., Adam G., Pfeiffer B., Renard P., Guillaumet G. J. Med. Chem. 37:1994;1779.
29. Sheldrick G.M. Sheldrick G.M., Kröger C., Goddard R. Crystallographic Computing 3. 1985;175 Oxford University Press, Oxford.
30. Supplementary X-ray Crystallographic data: Cambridge Crystallographic Data Centre, University Chemical Lab; Lensfield Road Cambridge, CB2 1EW, UK, e-mail: http://www.deposit@chemcrys.cam.ac.uk.